1. Knight, L, Dale M, Morgan H, Morris R. (external assessment report). UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia. 2021. https://www.nice.org.uk/guidance/mtg58/documents/supporting-documentation
2. NICE 2021, UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia (MTG58). https://www.nice.org.uk/guidance/mtg58. Accessed 04 May 2021
3. NICE 2015, UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia(MTG26). https://www.nice.org.uk/guidance/mtg26. Accessed 16 Sept 2016
4. Ray A, Morgan H, Wilkes A, Carter K, Carolan-Rees G. The Urolift system for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a NICE medical technology guidance. Appl Health Econ Health Policy. 2016;14(5):515–26.
5. Roehrborn C, Rukstalis DB, Barkin J, Gange SN, Shore ND, Giddens JL, Bolton DM, Cowan BE, Cantwell AL, McVary KT, Te AE. Three year results of the prostatic urethral LIFT study. Can J Urol. 2015;22(3):7772–82.